It would be interested to test the effects, if any, of a GLP-1 antagonist (e.g. exendin-(9-39): Thorens B, Porret A, Buhler L, Deng SP, Morel P, et al. Diabetes 1993) on these opioid-related experiments and outcomes. The gene discussed is GLP1R; the disease is diabetes mellitus.